Screener
Denali Therapeutics Inc. DNLI Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s finance lease liabilities?
- Denali Therapeutics Inc. (DNLI) reported finance lease liabilities of $5.48M in Q2 2026.
- How has Denali Therapeutics Inc.'s finance lease liabilities changed year-over-year?
- Denali Therapeutics Inc.'s finance lease liabilities decreased by 1.8% year-over-year, from $5.58M to $5.48M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Denali Therapeutics Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude